U.S. Transgender Industry Rejects Warnings from British Science Report

U.S. Transgender Industry Rejects Warnings from British Science Report


The U.S. medical establishment is dismissing a prestigious science report sponsored by the British government that is very critical of transgender medical claims, according to the New York Times.

Britain’s medical system pumped the brakes on transgender procedures on minors because the much-praised Cass Report found very little scientific evidence that transing drug therapies or surgeries are the proper mode of treatment for gender dysphoria.

Unfortunately, the U.S. medical establishment is ignoring the far-reaching report and is doubling down on the left-wing political lobby supporting the transgender movement.

The report sponsored by the U.K.’s National Health Service (NHS) — the country’s government-run health system — was quickly adopted by the government after revealing that there is little evidence that indiscriminate puberty-blocking drug therapies

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!